Life-threatening infections with a new strain of Clostridium difficile;Levensbedreigende infecties met een nieuwe variant van Clostridium difficile

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 38, 2005, Pages 2081-2086

  Krausz, S ^a   Bessems, M ^a   Boermeester, M A ^a   Kuijper, E J ^b   Visser, C E ^a   Speelman, P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ABDOMINAL SURGERY; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BACTERIAL STRAIN; CASE REPORT; CLOSTRIDIUM DIFFICILE; DIARRHEA; HUMAN; HYGIENE; INTENSIVE CARE UNIT; MALE; PSEUDOMEMBRANOUS COLITIS; RECURRENT DISEASE; SEPSIS; TOTAL COLON RESECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; MALE; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; RIBOTYPING; VIRULENCE;

EID: 25144491126     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Valiquette L, Low DE, Pépin J, McGeer A. Clostridium difficile infection in hospitals: a brewing storm. CMAJ 2004;171:27-9.
2. Kuijper EJ, Debast SB, Kregten E van, Vaessen N, Notermans DW, Broek PJ van den. Clostridium difficile ribotype 027, toxinotype III in Nederland. Ned Tijdschr Geneeskd 2005;149:2087-9.
3. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-72.
4. Berg RJ van den, Ameen HA, Furusawa T, Claas EC, Vorm ER van der, Kuijper EJ. Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol 2005;54(Pt 2):173-9.
5. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
6. Pépin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-7.
7. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005;18:247-63.
8. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999;37:461-3.
9. Rupnik, M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 1998;36: 2240-7.
10. Wilkins TD, Lyerly DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 2003;41:531-4.
11. Kuijper EJ, Weerdt J de, Kato H, Kato N, Dam AP van, Vorm ER van der, et al. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 2001;20:528-34.
12. Berg RJ van den, Bruijnesteijn van Coppenraet LS, Gerritsen HJ, Endtz HP, Vorm ER van der, Kuijper EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid detection of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol [ter perse].
13. Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004;38:646-8.
14. Oh H, Edlund C. Mechanism of quinolone resistance in anaerobic bacteria. Clin Microbiol Infect 2003;9:512-7.
15. Stirling B, Littlejohn P, Willbond ML. Nurses and the control of infectious disease. Understanding epidemiology and disease transmission is vital to nursing care. Can Nurse 2004;100:16-20.
16. Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-90.
17. Gerding DN. Metronidazole for Clostridium difficile-associated disease: is it okay for mom? Clin Infect Dis 2005;40:1598-600.
18. Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2005;(1):CD004610.
19. Fekety R, Silva J, Kauffman C, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989;86:15-9.
20. Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut 1986;27:1169-72.
21. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75.
22. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357:189-93.
23. Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997;41:366-70.
24. Sougioultzis S, Kyne L, Drudy D, Keates S, Maroo S, Pothoulakis C, et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005;128:764-70.
25. Dissel JT van, Groot N de, Hensgens CM, Numan S, Kuijper EJ, Veldkamp P, et al. Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostrium difficile-associated diarrhoea: preclinical and preliminary clinical data. J Med Microbiol 2005;54(Pt 2): 197-205.